- Home
- FTS vs BNTX Comparison
FTS vs BNTX Comparison
Compare FTS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTS | BNTX |
|---|---|---|
| Founded | 1885 | 2008 |
| Country | Canada | Germany |
| Employees | 9900 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0B | 24.2B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FTS | BNTX |
|---|---|---|
| Price | $55.90 | $87.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $67.00 | ★ $133.46 |
| AVG Volume (30 Days) | 511.9K | ★ 753.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.05 | N/A |
| Revenue Next Year | $5.32 | $3.37 |
| P/E Ratio | $22.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.46 | $79.81 |
| 52 Week High | $58.78 | $124.00 |
Technical Indicators
Market Signals| Indicator | FTS | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 39.18 |
| Support Level | $54.93 | $86.16 |
| Resistance Level | $57.67 | $113.32 |
| Average True Range (ATR) | 0.85 | 2.57 |
| MACD | -0.06 | -0.18 |
| Stochastic Oscillator | 55.91 | 5.45 |
Price Performance
Historical ComparisonAbout FTS Fortis Inc.
Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving 3.5 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.